TWST
Price
$30.82
Change
-$1.79 (-5.49%)
Updated
May 9 closing price
Capitalization
1.98B
82 days until earnings call
XWEL
Price
$0.88
Change
+$0.02 (+2.33%)
Updated
May 9 closing price
Capitalization
7.06M
Ad is loading...

TWST vs XWEL

Header iconTWST vs XWEL Comparison
Open Charts TWST vs XWELBanner chart's image
Twist Bioscience
Price$30.82
Change-$1.79 (-5.49%)
Volume$1.16M
Capitalization1.98B
XWELL
Price$0.88
Change+$0.02 (+2.33%)
Volume$25.44K
Capitalization7.06M
TWST vs XWEL Comparison Chart
Loading...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XWEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TWST vs. XWEL commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TWST is a StrongBuy and XWEL is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (TWST: $30.82 vs. XWEL: $0.88)
Brand notoriety: TWST and XWEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TWST: 95% vs. XWEL: 40%
Market capitalization -- TWST: $1.98B vs. XWEL: $7.06M
TWST [@Medical Specialties] is valued at $1.98B. XWEL’s [@Medical Specialties] market capitalization is $7.06M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TWST’s FA Score shows that 0 FA rating(s) are green whileXWEL’s FA Score has 1 green FA rating(s).

  • TWST’s FA Score: 0 green, 5 red.
  • XWEL’s FA Score: 1 green, 4 red.
According to our system of comparison, XWEL is a better buy in the long-term than TWST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TWST’s TA Score shows that 5 TA indicator(s) are bullish while XWEL’s TA Score has 4 bullish TA indicator(s).

  • TWST’s TA Score: 5 bullish, 3 bearish.
  • XWEL’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TWST is a better buy in the short-term than XWEL.

Price Growth

TWST (@Medical Specialties) experienced а -21.46% price change this week, while XWEL (@Medical Specialties) price change was +11.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

TWST is expected to report earnings on Aug 01, 2025.

XWEL is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TWST($1.98B) has a higher market cap than XWEL($7.06M). TWST YTD gains are higher at: -33.678 vs. XWEL (-41.722). XWEL has higher annual earnings (EBITDA): -17.82M vs. TWST (-172.41M). TWST has more cash in the bank: 311M vs. XWEL (26.1M). XWEL has less debt than TWST: XWEL (11.5M) vs TWST (91.9M). TWST has higher revenues than XWEL: TWST (262M) vs XWEL (30.3M).
TWSTXWELTWST / XWEL
Capitalization1.98B7.06M28,086%
EBITDA-172.41M-17.82M968%
Gain YTD-33.678-41.72281%
P/E RatioN/AN/A-
Revenue262M30.3M865%
Total Cash311M26.1M1,192%
Total Debt91.9M11.5M799%
FUNDAMENTALS RATINGS
TWST vs XWEL: Fundamental Ratings
TWST
XWEL
OUTLOOK RATING
1..100
549
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
9294
PRICE GROWTH RATING
1..100
9165
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
9585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (43) in the Biotechnology industry is in the same range as XWEL (65) in the Other Consumer Services industry. This means that TWST’s stock grew similarly to XWEL’s over the last 12 months.

TWST's Profit vs Risk Rating (97) in the Biotechnology industry is in the same range as XWEL (100) in the Other Consumer Services industry. This means that TWST’s stock grew similarly to XWEL’s over the last 12 months.

TWST's SMR Rating (92) in the Biotechnology industry is in the same range as XWEL (94) in the Other Consumer Services industry. This means that TWST’s stock grew similarly to XWEL’s over the last 12 months.

XWEL's Price Growth Rating (65) in the Other Consumer Services industry is in the same range as TWST (91) in the Biotechnology industry. This means that XWEL’s stock grew similarly to TWST’s over the last 12 months.

XWEL's P/E Growth Rating (2) in the Other Consumer Services industry is significantly better than the same rating for TWST (100) in the Biotechnology industry. This means that XWEL’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TWSTXWEL
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 18 days ago
79%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 7 days ago
80%
N/A
View a ticker or compare two or three
Ad is loading...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XWEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRECX10.230.07
+0.69%
Goldman Sachs Real Estate Securities C
FICCX70.880.21
+0.30%
Fidelity Advisor Canada I
JLCAX18.94N/A
N/A
JPMorgan US Large Cap Core Plus A
FSMDX33.24-0.01
-0.03%
Fidelity Mid Cap Index
MSSMX10.12-0.07
-0.69%
Morgan Stanley Inst Inception A

XWEL and

Correlation & Price change

A.I.dvisor tells us that XWEL and DRIO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XWEL and DRIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XWEL
1D Price
Change %
XWEL100%
+2.12%
DRIO - XWEL
28%
Poorly correlated
+7.13%
XRAY - XWEL
23%
Poorly correlated
-0.63%
NVCR - XWEL
22%
Poorly correlated
-0.34%
CHEK - XWEL
21%
Poorly correlated
-6.90%
ALGN - XWEL
21%
Poorly correlated
+0.53%
More